28 years of historical data (1998–2025) · Healthcare · Medical - Diagnostics & Research
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
ICON Public Limited Company trades at 50.3x earnings, 14% below its 5-year average of 58.5x, sitting at the 93rd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 128%. On a free-cash-flow basis, the stock trades at 13.0x P/FCF, 47% below the 5-year average of 24.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11.2B | $14.4B | $17.4B | $23.4B | $16.0B | $21.1B | $10.4B | $9.4B | $7.1B | $6.2B | $4.2B |
| Enterprise Value | $14.1B | $17.3B | $20.5B | $27.0B | $20.6B | $26.0B | $10.0B | $9.3B | $7.0B | $6.2B | $4.4B |
| P/E Ratio → | 50.34 | 62.83 | 22.01 | 38.25 | 31.69 | 137.64 | 31.25 | 25.37 | 21.90 | 21.86 | 16.17 |
| P/S Ratio | 1.35 | 1.74 | 2.10 | 2.88 | 2.07 | 3.85 | 3.71 | 3.34 | 2.72 | 3.50 | 2.55 |
| P/B Ratio | 1.25 | 1.57 | 1.83 | 2.53 | 1.89 | 2.61 | 5.62 | 5.78 | 5.22 | 5.00 | 4.49 |
| P/FCF | 12.97 | 16.69 | 15.57 | 22.95 | 38.04 | 28.67 | 19.11 | 25.86 | 32.80 | 126.32 | 19.58 |
| P/OCF | 10.79 | 13.89 | 13.53 | 20.17 | 28.44 | 25.42 | 17.47 | 22.68 | 26.79 | 126.25 | 16.36 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
ICON Public Limited Company's enterprise value stands at 10.1x EBITDA, 45% below its 5-year average of 18.5x. The Healthcare sector median is 14.2x, placing the stock at a 29% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.10 | 2.47 | 3.32 | 2.66 | 4.74 | 3.57 | 3.31 | 2.71 | 3.54 | 2.64 |
| EV / EBITDA | 10.10 | 12.40 | 12.91 | 17.49 | 14.58 | 35.15 | 20.54 | 17.69 | 16.00 | 15.57 | 11.85 |
| EV / EBIT | 13.91 | 39.26 | 19.04 | 28.84 | 25.78 | 68.52 | 25.32 | 21.11 | 18.58 | 18.26 | 13.75 |
| EV / FCF | — | 20.07 | 18.31 | 26.44 | 48.82 | 35.32 | 18.36 | 25.68 | 32.59 | 127.68 | 20.30 |
Margins and return-on-capital ratios measuring operating efficiency
ICON Public Limited Company earns an operating margin of 12.3%. ROE of 2.5% is modest. ROIC of 6.2% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.4% | 26.4% | 29.4% | 29.6% | 28.6% | 27.5% | 28.9% | 29.6% | 29.6% | 41.3% | 42.3% |
| Operating Margin | 12.3% | 12.3% | 13.3% | 11.8% | 10.3% | 6.9% | 14.0% | 15.4% | 14.4% | 19.2% | 18.7% |
| Net Profit Margin | 2.8% | 2.8% | 9.6% | 7.5% | 6.5% | 2.8% | 11.7% | 13.3% | 12.4% | 16.0% | 15.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.5% | 2.5% | 8.4% | 6.9% | 6.1% | 3.1% | 18.9% | 25.2% | 25.0% | 25.9% | 30.7% |
| ROA | 1.4% | 1.4% | 4.7% | 3.6% | 2.9% | 1.5% | 10.3% | 14.2% | 14.2% | 14.0% | 14.8% |
| ROIC | 6.2% | 6.2% | 6.5% | 5.6% | 4.6% | 3.9% | 19.6% | 22.7% | 21.5% | 21.2% | 22.1% |
| ROCE | 7.5% | 7.5% | 7.8% | 6.7% | 5.4% | 4.4% | 19.2% | 24.6% | 22.2% | 22.9% | 25.2% |
Solvency and debt-coverage ratios — lower is generally safer
ICON Public Limited Company carries a Debt/EBITDA ratio of 2.5x, which is moderately leveraged (21% below the sector average of 3.2x). Net debt stands at $2.9B ($3.6B total debt minus $647M cash). Interest coverage of just 2.3x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.39 | 0.38 | 0.43 | 0.57 | 0.70 | 0.23 | 0.28 | 0.26 | 0.28 | 0.37 |
| Debt / EBITDA | 2.55 | 2.55 | 2.27 | 2.55 | 3.43 | 7.64 | 0.89 | 0.87 | 0.80 | 0.87 | 0.94 |
| Net Debt / Equity | — | 0.32 | 0.32 | 0.39 | 0.53 | 0.61 | -0.22 | -0.04 | -0.03 | 0.05 | 0.17 |
| Net Debt / EBITDA | 2.08 | 2.08 | 1.93 | 2.31 | 3.22 | 6.62 | -0.84 | -0.13 | -0.11 | 0.17 | 0.42 |
| Debt / FCF | — | 3.37 | 2.74 | 3.49 | 10.78 | 6.65 | -0.75 | -0.18 | -0.22 | 1.36 | 0.72 |
| Interest Coverage | 2.34 | 2.34 | 4.53 | 2.78 | 3.47 | 2.08 | 30.28 | 33.16 | 28.00 | 26.98 | 24.59 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.10x means ICON Public Limited Company can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.21x to 1.10x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.10 | 1.10 | 1.26 | 1.21 | 1.20 | 1.19 | 1.87 | 1.44 | 2.18 | 1.95 | 1.94 |
| Quick Ratio | 1.10 | 1.10 | 1.26 | 1.21 | 1.20 | 1.19 | 1.87 | 1.43 | 2.17 | 1.94 | 1.93 |
| Cash Ratio | 0.20 | 0.20 | 0.19 | 0.13 | 0.11 | 0.30 | 0.75 | 0.50 | 0.75 | 0.64 | 0.53 |
| Asset Turnover | — | 0.51 | 0.49 | 0.48 | 0.45 | 0.32 | 0.81 | 0.97 | 1.10 | 0.80 | 0.91 |
| Inventory Turnover | — | — | — | — | 782.54 | — | — | 616.92 | 794.04 | 468.85 | 400.56 |
| Days Sales Outstanding | — | 121.61 | 125.66 | 130.32 | 132.09 | 138.05 | 157.55 | 131.85 | 117.78 | 146.58 | 145.04 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
ICON Public Limited Company returns 6.7% to shareholders annually primarily through share buybacks. The earnings yield of 2.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.0% | 1.6% | 4.5% | 2.6% | 3.2% | 0.7% | 3.2% | 3.9% | 4.6% | 4.6% | 6.2% |
| FCF Yield | 7.7% | 6.0% | 6.4% | 4.4% | 2.6% | 3.5% | 5.2% | 3.9% | 3.0% | 0.8% | 5.1% |
| Buyback Yield | 6.7% | 5.2% | 2.9% | 0.0% | 0.6% | 0.0% | 1.7% | 1.6% | 1.8% | 2.2% | 2.6% |
| Total Shareholder Yield | 6.7% | 5.2% | 2.9% | 0.0% | 0.6% | 0.0% | 1.7% | 1.6% | 1.8% | 2.2% | 2.6% |
| Shares Outstanding | — | $79M | $83M | $83M | $82M | $68M | $53M | $54M | $55M | $55M | $56M |
Compare ICLR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $11B | 50.3 | 10.1 | 13.0 | 26.4% | 12.3% | 2.5% | 6.2% | 2.5 | |
| $9B | -63.6 | 12.9 | 17.2 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 | |
| $28B | 21.4 | 12.4 | 13.9 | 26.3% | 14.0% | 21.4% | 8.7% | 4.7 | |
| $13B | 30.1 | 22.9 | 19.3 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 | |
| $1B | 24.9 | 19.5 | — | 39.4% | 6.6% | 4.0% | 3.2% | 5.1 | |
| $21B | 24.5 | 12.6 | 17.5 | 26.8% | 10.9% | 10.5% | 7.8% | 3.3 | |
| $22B | 22.3 | 12.9 | 15.9 | 31.9% | 14.5% | 14.0% | 8.8% | 3.2 | |
| $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 | |
| $173B | 26.2 | 18.7 | 27.4 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 | |
| $125B | 35.2 | 18.4 | 23.8 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 28 years · Updated daily
Deep dive into ICLR consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ICLR stock.
ICON Public Limited Company's current P/E ratio is 50.3x. The historical average is 25.7x. This places it at the 93th percentile of its historical range.
ICON Public Limited Company's current EV/EBITDA is 10.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.2x.
ICON Public Limited Company's return on equity (ROE) is 2.5%. The historical average is 14.2%.
Based on historical data, ICON Public Limited Company is trading at a P/E of 50.3x. This is at the 93th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
ICON Public Limited Company has 26.4% gross margin and 12.3% operating margin. Operating margin between 10-20% is typical for established companies.
ICON Public Limited Company's Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.